How to Get Armour Thyroid in California

What Is Armour Thyroid and Why Do California Patients Seek It

Armour Thyroid is a prescription desiccated thyroid extract (DTE) tablet containing both T4 and T3 hormones derived from porcine thyroid glands. Patients who continue to experience fatigue, cognitive symptoms, or weight irregularities on levothyroxine monotherapy often ask their physicians about DTE as an alternative. California has a large and active integrative medicine community, which partly explains the high search volume for this medication in the state.

The FDA-approved label for Armour Thyroid lists hypothyroidism as its primary indication, covering primary, secondary, tertiary, and subclinical disease when treatment is clinically warranted [1]. Each 60 mg (1-grain) tablet contains approximately 38 mcg T4 and 9 mcg T3, giving it a T4:T3 ratio of roughly 4:1. That ratio differs from the approximately 14:1 ratio of human thyroid secretion, which is one reason some clinicians combine DTE with small doses of levothyroxine [2].

A 2013 randomized crossover trial by Hoang et al. (N=70) found that 49% of participants preferred DTE over levothyroxine, compared with 19% who preferred levothyroxine (P<0.001). Patients on DTE lost an average of 0.9 kg more than those on levothyroxine over 16 weeks [3]. The American Thyroid Association's 2014 guidelines acknowledge that DTE "cannot be recommended as a first-line therapy" but state that "for patients who do not prefer levothyroxine treatment, DTE may be considered" [4]. That language gives California prescribers a clear framework for offering Armour Thyroid to appropriately selected patients.

Who Can Prescribe Armour Thyroid in California

Any California-licensed prescriber with authority to write for non-controlled medications may prescribe Armour Thyroid. That group includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs).

California Business and Professions Code Section 2836.1 grants NPs standardized procedure authority, and California Business and Professions Code Section 3502 authorizes PAs to prescribe under physician supervision or, since January 2024, under a more independent practice model for experienced PAs [5]. In practice, endocrinologists, internal medicine physicians, family medicine physicians, and integrative medicine MDs/DOs are the most common Armour Thyroid prescribers in California. NPs working in thyroid-focused telehealth clinics write a substantial share of these prescriptions as well.

The California Medical Board does not restrict DTE prescribing to specialists. A general practitioner who documents a hypothyroidism diagnosis, obtains appropriate labs, and follows standard titration protocols can legally prescribe it. Endocrinology referral is appropriate when autoimmune thyroid disease is complex, when the patient has cardiovascular comorbidities, or when TSH remains uncontrolled after two or more dose adjustments [6].

Board-certified endocrinologists are not required, but they are often the clinicians best positioned to manage the T3 component of DTE in older patients or those with atrial fibrillation risk, because excess T3 can suppress TSH and raise cardiovascular event rates [7].

Labs Required Before an Armour Thyroid Prescription in California

A prescriber will order baseline labs before writing a DTE prescription. Skipping these tests creates both clinical and legal risk.

The minimum panel most California physicians use includes TSH, free T4 (FT4), and free T3 (FT3). TSH alone is insufficient because DTE suppresses TSH more readily than levothyroxine does, so post-treatment monitoring relies heavily on FT3 to avoid over-replacement [8]. TPO antibody testing identifies Hashimoto's thyroiditis, which is the most common cause of hypothyroidism in California adults and may influence dose stability over time [9].

A complete metabolic panel (CMP) and CBC assess liver function (thyroxine is hepatically cleared) and help rule out anemia, which can mimic hypothyroid fatigue [10]. Some clinicians also order reverse T3 (rT3) and thyroglobulin antibodies, particularly in integrative medicine settings, though these are not universally required before initiating therapy.

The Endocrine Society's 2012 clinical practice guideline recommends measuring TSH every 6-8 weeks after any dose change until levels stabilize, then annually [11]. For patients on DTE, most thyroid specialists add an FT3 measurement at each follow-up visit because T3 peaks 2-4 hours after a DTE dose and can temporarily exceed the reference range even when the patient is clinically euthyroid [12].

Reference ranges vary by laboratory. California patients using Quest Diagnostics or LabCorp will see TSH reference intervals of approximately 0.45-4.50 mIU/L, though many integrative practitioners target a narrower TSH of 1.0-2.0 mIU/L for symptom resolution [13].

How to Get an Armour Thyroid Prescription Through California Telehealth

California telehealth prescribing for Armour Thyroid is legal and widely available. The California Telehealth Advancement Act (Business and Professions Code Section 2290.5) permits synchronous audio-video encounters as the basis for a new prescription, provided the clinician performs an adequate history and review of relevant labs [14].

The standard telehealth pathway works as follows. First, you schedule a synchronous video visit with a California-licensed provider. Second, the provider reviews your lab results and symptom history. Third, if clinically appropriate, the provider sends a prescription electronically to your preferred California pharmacy or to a mail-order pharmacy licensed to ship into California. The entire process from booking to prescription transmission typically takes one to five business days with telehealth platforms that specialize in hormone therapy.

HealthRX clinicians use a four-step access framework for California DTE patients: (1) order labs at least 72 hours before the video visit, (2) complete a structured thyroid symptom questionnaire (including ThyPRO-39 items on fatigue, cognitive symptoms, and weight), (3) conduct a synchronous video evaluation with a licensed CA prescriber, and (4) transmit the prescription to a California-licensed pharmacy. Patients who follow this sequence receive their prescription on the same day as their video visit in the majority of cases.

The California telehealth model does have one constraint: prescribers cannot rely on asynchronous "store-and-forward" messaging alone to initiate a new prescription for a systemic medication like Armour Thyroid. A real-time synchronous encounter is required for the first prescription. Refills may be handled asynchronously once the therapeutic relationship is established [15].

Medi-Cal managed care plans operating in California cover telehealth visits for thyroid evaluation, which means low-income patients can access DTE through a virtual visit without an out-of-pocket visit cost. Prior authorization for the medication itself remains a separate step covered in the section below [16].

Prior Authorization for Armour Thyroid in California: Step-by-Step

Medi-Cal and many California commercial insurers require prior authorization (PA) before covering Armour Thyroid. The documentation burden is manageable but specific.

Medi-Cal's Drug Utilization Review criteria require documentation of a confirmed hypothyroidism diagnosis (ICD-10 code E03.9 or more specific), at least one TSH lab result above the normal range, and a clinical note explaining why levothyroxine is not being used or why it was discontinued [17]. Some plans also require documentation of a trial of levothyroxine at an adequate dose (typically 50-100 mcg/day for at least 6 weeks) before approving DTE.

For commercial plans, the PA request typically includes the following: a letter of medical necessity from the prescribing clinician, lab results showing hypothyroidism, the patient's symptom history, and the prescriber's rationale for DTE over generic levothyroxine. The Endocrine Society's position that DTE "may be considered" for patients who prefer it over levothyroxine [4] is frequently cited in PA letters to support coverage.

California Health and Safety Code Section 1367.241 requires health plans to issue PA decisions for non-urgent medications within 72 hours of receiving a complete request [18]. If the insurer denies the PA, California Insurance Code Section 10169 provides an independent medical review process through the California Department of Managed Health Care [19].

Patients without insurance or with a denied PA have two practical options. They can pay out of pocket, where Armour Thyroid typically costs $30-80 per month depending on dose and pharmacy. They can also ask their prescriber about a 503A compounded NDT preparation, which is covered in the next section.

California Pharmacies That Fill Armour Thyroid

Armour Thyroid is a commercially manufactured tablet available at most major retail and mail-order pharmacies licensed in California. CVS, Walgreens, Rite Aid, Costco Pharmacy, and independent compounding pharmacies all stock or can order it. The National Drug Code (NDC) for Armour Thyroid is assigned to Allergan, and the product is not on any California drug shortage list as of the date of this article.

GoodRx and similar discount programs bring the cash price of a 30-day supply (60 mg, 1 grain, 30 tablets) to approximately $28-45 at California retail pharmacies. Higher doses cost proportionally more. Patients on 90 mg (1.5 grains) or 120 mg (2 grains) daily should compare prices across pharmacies, as pricing variation across California ZIP codes can exceed 40% for the same NDC [20].

503A compounding pharmacies licensed by the California State Board of Pharmacy can prepare customized NDT formulations when a commercially available strength does not meet a specific patient need. The California State Board of Pharmacy maintains an online license verification database where patients can confirm a pharmacy's 503A status before purchasing a compounded product [21]. Compounded NDT is not FDA-approved and does not carry the same manufacturing quality standards as commercially manufactured Armour Thyroid, a distinction the FDA emphasizes in its guidance on compounded thyroid products [22].

Mail-order pharmacies licensed to ship into California can also fill Armour Thyroid prescriptions. California law requires that out-of-state pharmacies hold a non-resident pharmacy permit issued by the California State Board of Pharmacy before shipping prescription medications to California addresses [23]. Patients should verify this permit before using any online pharmacy service.

Transferring an Existing Armour Thyroid Prescription to California

Patients moving to California with an active Armour Thyroid prescription from another state can transfer the prescription to a California pharmacy. California Business and Professions Code Section 4076 and the corresponding regulations permit prescription transfers for non-controlled medications between licensed pharmacies in different states [24].

The practical steps are straightforward. Contact the California pharmacy where you want to fill the prescription and give them the name and phone number of your previous pharmacy. The California pharmacy's staff will call to transfer the prescription record. Because Armour Thyroid is not a controlled substance, there is no federal restriction on interstate transfer.

One caveat applies: some California insurers will not cover a transferred prescription without a California-licensed prescriber on file. If your previous prescriber was out of state and you are using California insurance, you may need a new evaluation with a California-licensed clinician to establish coverage. A single telehealth visit with a California-licensed physician, NP, or PA is usually sufficient to create that relationship and write a new California prescription [15].

Patients who transferred from a state that used a compounded NDT product should note that the compounding order is non-transferable. Compounding prescriptions are patient-specific and pharmacy-specific under federal USP 795 guidelines [25]. They will need a new prescription written specifically for a California 503A pharmacy.

Dosing, Titration, and Monitoring Protocols for California Patients

Armour Thyroid dosing follows a grain-based system inherited from its pre-FDA history. One grain equals 60 mg and contains approximately 38 mcg T4 plus 9 mcg T3. Most adults start at 30 mg (½ grain) daily and titrate upward by 15-30 mg every 6-8 weeks based on labs and symptoms [26].

The FDA-approved prescribing information states that the average full replacement dose in adults is 60-120 mg per day [1]. Older patients (age 65 and above) and those with cardiac disease should start at 15-30 mg and titrate more slowly, given T3's faster onset and greater cardiovascular potency compared with T4 [7]. A 2017 study in JAMA Internal Medicine found that excess thyroid hormone exposure, including subclinical hyperthyroidism, was associated with a 1.68-fold increased risk of atrial fibrillation in adults over 65 (95% CI 1.16-2.43) [27]. That finding makes slow titration and close TSH monitoring especially important in older California patients.

Take Armour Thyroid on an empty stomach, ideally 30-60 minutes before breakfast or other medications. Calcium carbonate, iron supplements, proton pump inhibitors, and certain cholesterol medications reduce thyroid hormone absorption and should be separated by at least four hours [28]. Coffee consumed within 30 minutes of a DTE dose has been shown to reduce T4 absorption by approximately 36% in studies using levothyroxine as a surrogate marker [29].

Monitoring after each dose change requires TSH and FT3 at the 6-8 week mark. Because T3 peaks 2-4 hours post-dose, patients should take their Armour Thyroid at the same time on lab draw days and note the time of the last dose on the requisition form. Drawing labs without this information makes FT3 interpretation unreliable [12].

Once stable, annual TSH plus FT3 monitoring is standard for most patients. Women planning pregnancy require more frequent monitoring: TSH should be checked at diagnosis of pregnancy and every 4 weeks during the first trimester, because thyroid hormone requirements typically increase by 25-50% in the first weeks of gestation [30].

What to Expect From Your First California Armour Thyroid Appointment

Most California patients describe symptom improvement within two to four weeks of reaching their optimal dose, though full benefit may take three to six months [31]. The most commonly reported early improvements are reduction in fatigue and improvement in cold intolerance. Weight changes, cognitive clarity, and mood tend to improve more gradually.

Expect your prescriber to contact you at the 6-8 week mark for a lab review. If TSH has fallen below 0.5 mIU/L or FT3 is above the upper reference limit, your dose will likely be reduced. If TSH remains elevated and symptoms persist, your dose will be increased by 15-30 mg. This titration process repeats until you reach a stable, symptom-free state with labs in the target range.

Some patients experience palpitations, increased sweating, or insomnia during the first weeks of DTE therapy. These symptoms may indicate mild T3 excess and should be reported to your prescriber promptly rather than managed by stopping the medication on your own. A dose reduction of one-half grain is usually sufficient to resolve these effects [1].

California-based patients can expect ready access to follow-up lab review via their telehealth provider's patient portal, which reduces the need for in-person visits after the initial consultation.